Member Info for JustHereForHemo

I think its worth a bit of perspective here, I dont care if it costs $1m a year for these new facilities, they are to enable Hemogenyx to produce in house CAR for CAR-T plus god knows what else..... They have like 9-10mil in the bank, I am confident they can afford the rent.
If they were not doing it in house they would be paying a fortune to some other company to manufacture on their behalf. This will be cheaper and faster and cuts out yet another middleman.

It does show an evolution in the de-rampers though, 6 months ago all we heard was CDX has been binned does not work, past few weeks its been constant calls for placing after placing despite the fact Vlad has categorically stated its not happening. We have heard that Hemo will have to pay millions to Eli Lilly for their IP. Basically de-rampers working down a list that just keeps getting disproved over and over again. We are now onto:
"They may have to pay for flights"
and
"They are growing and developing so fast they may have to pay more rent."
Comical ;-D

For those disappointed with the speed and progress... The rns says: "We will be growing our staff and operations significantly over the next three years"
It does not say:
"we will be sitting on our ar$€ for the next 2 years and 11 months only to grow our staff and operations significantly at the 11th hour"

Evening all, dingo I partially agree however many have had that attitude in the past, in particular before the clns were drawn down and when we were waiting for them to be cancelled. We know how that turned out, double the shares and less than half of the mCap. Share price matters. The only saving grace is the guarantee from vlad about no placing so sp does not really matter for the next 6 months or so.

I asked the question for you. It has been answered.
NO PLACING, official from the CEO.
They are looking at non dilutive funding for the future.
Enjoy your weekend everyone I'm off for a few days away.

There was like 200m+ dumped before the were added, but I would be more inclined to agree that it could be placing shares if there had been a tr1 but there wasn't. God knows what's going on, God and the mms..

I disagree with people saying it will take years now but before anyone jumps down my neck I agree that CDX will take probably a year before it gets to clinical trials. HOWEVER CAR-T they have already lined up 2 companies according to the last update and are pretty damn close to IND application and clinical studies. Then there is CBR which to date we know nothing about, could be big. People are right to call out that CDX is still a bit off clinical trials but Hemo is not a one trick zebra.
Then there is the cold hard fact, Hemo are sitting at £20m. They have £10m in cash and have just acquired IP from Eli Lilly, multiple patents and patent applications fired and pre-existing licencing entitlements from other Pharma. We can argue about how much all that is worth but I doubt very much anyone on here thinks its only worth £10m.
I have been saying for a long time(and getting alot of abuse for it) it feels like this share has been under attack for months, I dont really care what the reason it just really peeves me off. I will post my wildest theories for entertainment value:

1, After the placing we got a new MM, Marex, they came in with no shares but sold plenty, they borrowed millions and have basically been shorting ever since. Reason why they have not let the SP go? They expected the SP to hit 1.5p and needed it too to make the profits they were after, it never got close so they will keep taking the pee until they make what they want.

2, In 12 days the 52 week high drops from 12pps to 9.65p I think. Its currently 88m to buy Hemo outright incl all the IP, thats 30% at 2p and 70% at 9.65. In 12 days it costs 72m to buy them outright because of the new 52w high. Whoever it is has only to suppress the SP for 12 more days to save £16mil. Do a chop shop on hemo, sell off CDX and CAR-T for bargain basement profits and pocket a massive profit.

3, Nobody from the placing at 1.5p filed a TR1 but then again clearly some of them dumped so perhaps they are just totally dishonest and didnt dump as many up front as we suspect, held more than 3% and have just never declared? And they really are just dumping on any and all volume from the placing to now for any price above 2p just to clear them.

Thats my 3 most extreme theories, perhaps I am right, perhaps not. Its also possible that investors are just so scarred and burned from some bad management over the past year and failure to deliver that they had always decided they were going to sell on the CDX deal irrespective of the SP and with a complete lack of volume in the market there was no new blood there to buy up the slack.

Enjoy my ramblings, have a nice evening and remember, as you slide down the banister of life may the splinters never point the wrong way.

Stu - Vlad owns ALOT of stock, but I too would love to see the board backing the company and buying shares, seems only Andrew ever buys, I am sure the rest of them could buy a few thousand in support.

Anyway - Out and about today, hopefully market is a bit kinder to us and we see a bit of recovery.

Barber, I dont think there will be any shares in issue at stage 3 and thats my opinion. I think Vlad has to prove CDX works in humans before EL are willing to take it and at that point because of Lupus and the mice and other collaborations ongoing they will just buy the company, probably easier than multiple licences and hardly expensive for them. The trials will be Phase 1/2a they will be cancer patients who will either live or die and probably rather sick ones at that. IMO there will never be another placing but their could be. I do know that they are considering non dilutive funding now such as grants and the like, I sent them an email about 6 months ago with a page of charities and grants and sponsorships open to them, there is ALOT of free money out there, but again its not needed YET.

I am not dismissing the cost of clinical trials, I am just saying, at present its not an issue.

The mCap is £20m.... 10mil in the bank. 2 products approaching clinical trials and they are funded though phase 1. Human patients will be treated before any future fund raises are required. IS pharma high risk? Ofcourse it is and should be priced accordingly, but £20m is not appropriate. We really need some Bio investors posting on here doing some actual comparisons, market valuations risk v reward analysis.

tweetstreet - Pretty fair post, 2 points though, 1 this was the preferred option of Vlad as Hemo can progress CDX to clinical trials faster than EL and can sublicence CDX for conditions EL are not interested in to other Pharma if oppertunities arise nothing at all to do with EL not believing in the product. Second I see plenty of people seeing crypto as a better investment and chasing rainbows there, they may well be right but IMO its a bubble and will burst sooner rather than later.
Anyway I know Hemo are not happy with the current SP understandably so, they expected the blip to end with this licencing deal but the market has clearly not responded as expected. I dont expect them to take it laying down, not sure exactly what they will do next but I have not and will not be selling as I remain convinced this will recover and bounce hard at some point.

Good ole barber, only turns up to put the boot in once in a blue moon. You took my point, twisted it and turned it completely ar$e about face.
What I said was CDX or CAR-T etc just going into clinical trials are only worth about 10% or so of their final licencing value at this point. But the final licencing value is about 1b at a rough guess, lets say they are only worth even 500mil for BOTH, 10% of that is 50mil. Yet the mCap is sitting at what? < £20mil and yes they have 10mil of that in the bank.
Sorry but no this current SP and mCap is pure and utter BS, it bears no resemblance to the recent achievements and does not value the IP and patents secured to date nor the potential, but please Barber go ahead and value hemo for us. Tell us what the company is worth? What exactly is CDX and the patents worth? Please enlighten us?

OK Tweetstreet let's take your comment that your at a loss, just like most LTH'ers, so are you telling me that Hemo is worth LESS today than it was 12 months ago when the mCap was 50m+?
Thats the place we are at, we are a year on with hemogenyx currently owning multiple powerful patents, now they own IP from Eli Lilly, they are close to clinical trials for not one but 2 products. Forget about CBR and Hu-phec. MCap is 20mil, 10mil of that they have in cash so are people saying everything that hemo own is worth just 10mil? I hear that candidates can be worth as little as 10% of their value if bought at this stage vs at phase 3,so what does that value CDX at? A potential replacement for chemotherapy worth less than 100m?
Sorry folks no, the sp is pure and utter bo77lok5, it will adjust at some point, and I'm stubborn enough to wait. Anyone who thinks the current sp is in anyway realistic should spend a bit of time looking at recent pharma licencing deals or takeovers. Smells of manupulation and it stinks.

Yea, the Agreement was fantastic and gives Vlad a path to his goal, I am happy with the progress, the SP baffles me but I dont need to sell so I am going to let the market do what it wants. The games cant last for ever surely?

Ofcourse the existing 9-10 mil will run out before phase 2 trials, that much is a given. But you could be talking 1-2 years, we dont know what could happen between now and then. Talking about a potential placing in 12 months is just pointless, in that time they could receive grants, they could sell a sub licence of CDX (As per the RNS) they could receive financial backing from Eli Lilly, they could be valued at 200mil in which case a placing at 20p is fine. Its all about the context. You made it sound like a placing was imminent not years down the line.

Well I am 100% satisfied that its not happening for the foreseeable future, but ill try and get one of the people who interview vlad to ask him if there is any placing in the immediate future if possible and then there wont be any debate about it, fair enough?

Auto complete should be Manufacturability

Phase 1/2a trials cost money, alot of money.... They also require an IND application. Which requires IND enabling studies and manoeuvrability studies which will likely take ATLEAST 3+ months.
Post away but dont make it sound like there is a placing coming tomorrow when that is absolutely false.
"Personally can't see how we go forward without a raise." - Why? So they cant just go ahead with the 9mil in the bank?

Gave up predicting how the SP and market will behave so nope, all I am sure about is no dilution incoming so I am at ease. No more BS about who Global Co is and eventually the market should pick up on the significance of CDX and the fact that Vlad can sell the same product to multiple Pharmas now.....

Your dedicating alot of time talking about placings and cash raises having not been around for a very long time. Funny that. Perhaps you should pick up your phone and ask the company what the cash situation is instead of picking up a narrative that suits you out of your bottom?

Mr India I think the only people talking about dilution or placing or the like are doing so because they have alteriour motives simple as that. Hemo have plenty of money in the bank and there will be no placing or dilution for the forseeable future. A very nominal fee was paid and the £1m will probably never be paid because by the time they finish phase 2 clinical trials Eli will probably have just bought the company. If they have not bought by then it will still be atleast a year away.
You should know by now I dont just pluck random guesses out of my backside, they are educated guesses often built on some sort of confirmatory steps. Just ignore the trolls who will use "placing" as their only way to attack the company now, its just bullplop.